Beck Bode, LLC Abbott Laboratories Transaction History

Beck Bode, LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 07, 2023	SELL	$95.06 - $111.52 $1.39 Million - $1.63 Million	-14,610 Reduced 68.74%	6,645 $729,000
Q3 2022 Nov 10, 2022	SELL	$96.76 - $112.03 $178,231 - $206,359	-1,842 Reduced 7.98%	21,255 $2.06 Million
Q2 2022 Jul 29, 2022	BUY	$102.07 - $123.37 $433,389 - $523,829	4,246 Added 22.52%	23,097 $2.51 Million
Q1 2022 May 02, 2022	BUY	$114.02 - $139.04 $2.15 Million - $2.62 Million	18,851 New	18,851 $2.23 Million
Q3 2021 Oct 22, 2021	SELL	$116.66 - $129.06 $126,926 - $140,417	-1,088 Closed	0 $0
Q2 2021 Jul 29, 2021	SELL	$105.79 - $124.53 $11.3 Million - $13.2 Million	-106,372 Reduced 98.99%	1,088 $126,000
Q1 2021 May 10, 2021	BUY	$108.84 - $128.23 $1.54 Million - $1.81 Million	14,144 Added 15.16%	107,460 $12.9 Million
Q3 2020 Nov 12, 2020	BUY	$91.64 - $111.29 $408,164 - $495,685	4,454 Added 5.01%	93,316 $10.2 Million
Q2 2020 Aug 13, 2020	BUY	$76.57 - $98.0 $1.44 Million - $1.84 Million	18,770 Added 26.78%	88,862 $8.13 Million
Q1 2020 May 14, 2020	SELL	$62.82 - $91.86 $390,551 - $571,093	-6,217 Reduced 8.15%	70,092 $6.46 Million
Q4 2019 Jan 27, 2020	BUY	$78.51 - $87.4 $56,134 - $62,491	715 Added 0.95%	76,309 $6.63 Million
Q3 2019 Dec 02, 2019	BUY	$81.84 - $88.74 $113,430 - $122,993	1,386 Added 1.87%	75,594 $6.33 Million
Q2 2019 Nov 27, 2019	BUY	$72.88 - $85.0 $177,754 - $207,315	2,439 Added 3.4%	74,208 $6.24 Million
Q1 2019 Nov 27, 2019	BUY	$66.22 - $80.06 $4.75 Million - $5.75 Million	71,769 New	71,769 $5.74 Million

3,186

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $206B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Beck Bode, LLC, based on Form 13F filings with the SEC.

Stay updated on Beck Bode, LLC with notifications on news.